0.93
price down icon1.46%   -0.0138
 
loading

Durect Corp (DRRX) 最新ニュース

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.12% - MSN

pulisher
MSN

Q2 2024 EPS Estimates for DURECT Co. Lifted by Analyst (NASDAQ:DRRX) - Defense World

pulisher
Defense World

DURECT Co. to Post FY2024 Earnings of ($0.90) Per Share, Northland Capmk Forecasts (NASDAQ:DRRX) - Defense World

pulisher
Defense World

Brokers Set Expectations for DURECT Co.'s Q2 2024 Earnings (NASDAQ:DRRX) - Defense World

pulisher
Defense World

Disclosure of trading in own shares from May 2nd to May 8th, 2024 - Yahoo Finance Australia

pulisher
Yahoo Finance Australia

Holland America Line Opens Bookings for 2026 Grand World Voyage, Unveils 2026 Grand Australia and New Zealand ... - Yahoo Finance Australia

pulisher
Yahoo Finance Australia

DURECT Corporation (NASDAQ:DRRX) Q1 2024 Earnings Call Transcript - Insider Monkey

pulisher
Insider Monkey

Earnings call: DURECT Corporation reports Q1 2024 results By Investing.com - Investing.com Australia

pulisher
Investing.com Australia

Earnings call: DURECT Corporation reports Q1 2024 results - Investing.com India

pulisher
Investing.com India

Earnings call: DURECT Corporation reports Q1 2024 results By Investing.com - Investing.com

pulisher
Investing.com

Exploring Three ASX Growth Companies With High Insider Ownership - Yahoo Finance UK

pulisher
Yahoo Finance UK

Top German Growth Companies With High Insider Ownership In May 2024 - Yahoo Finance Australia

pulisher
Yahoo Finance Australia

Durect (DRRX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

pulisher
Yahoo Finance

DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update - Yahoo Finance

pulisher
Yahoo Finance

Durect: Q1 Earnings Snapshot - Houston Chronicle

pulisher
Houston Chronicle

Carisma Therapeutics Inc. (CARM) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

pulisher
Yahoo Finance

State Street Corporation's (NYSE:STT) CEO Might Not Expect Shareholders To Be So Generous This Year - Yahoo Finance Australia

pulisher
Yahoo Finance Australia

Truist Financial Corp Has $2.56 Million Position in iShares Yield Optimized Bond ETF (NYSEARCA:BYLD) - Defense World

pulisher
Defense World

OP Financial Group's Interim Report for 1 January–31 March 2024: OP Financial Group reports a strong Q1 – operating ... - Yahoo Finance UK

pulisher
Yahoo Finance UK

DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update - InvestorsObserver

pulisher
InvestorsObserver

SLR Investment Corp. (NASDAQ:SLRC) Shares Sold by Atria Wealth Solutions Inc. - Defense World

pulisher
Defense World

DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM ... - PR Newswire

pulisher
PR Newswire

MAG Silver (NYSEAMERICAN:MAG) Shares Up 4% Following Analyst Upgrade - Defense World

pulisher
Defense World

Financial 15 Split Corp. Monthly Dividend Declaration for Class A & Preferred Share - Yahoo Finance UK

pulisher
Yahoo Finance UK

Durect Enters Co-Marketing & Collaboration Agreement with Charles River Laboratories - Contract Pharma

pulisher
Contract Pharma

Durect (DRRX) Reports Q4 Loss, Misses Revenue Estimates

pulisher
Zacks Investment Research

DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - PR Newswire

pulisher
PR Newswire

CRA Money: How to Get a Bigger Tax Refund in 2024 - Yahoo Canada Finance

pulisher
Yahoo Canada Finance

MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates

pulisher
Zacks Investment Research

Akebia Therapeutics (AKBA) Reports Break-Even Earnings for Q4

pulisher
Zacks Investment Research

Akebia Therapeutics (AKBA) Reports Break-Even Earnings for Q4 - Yahoo Finance

pulisher
Yahoo Finance

DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product ... - PR Newswire

pulisher
PR Newswire

Pacira (PCRX) Matches Q4 Earnings Estimates

pulisher
Zacks Investment Research

Top 3 Health Care Stocks That Are Preparing To Pump This Month

pulisher
Benzinga

Top 3 Health Care Stocks That Are Preparing To Pump This Month - Durect (NASDAQ:DRRX), Aadi Bioscience (N - Benzinga

pulisher
Benzinga

DRRX Stock Quote Price and Forecast - CNN

pulisher
CNN

Rare Stock Picks In November 2023 - From 31 Discerning Analysts

pulisher
Seeking Alpha

DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update - PR Newswire

pulisher
PR Newswire

U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.12% - Investing.com India

pulisher
Investing.com India

DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated ... - PR Newswire

pulisher
PR Newswire

These 2 'Strong Buy' Penny Stocks Have Massive Upside Potential, Says Oppenheimer - TipRanks.com - TipRanks

pulisher
TipRanks

The Top 25 Healthcare Technology Leaders of Houston for 2023 - The Healthcare Technology Report.

pulisher
The Healthcare Technology Report.

Want $5,000 in Passive Income Every Year? Here's How Much You'd Have to Invest - Yahoo Canada Finance

pulisher
Yahoo Canada Finance

DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - PR Newswire

pulisher
PR Newswire

DURECT Completes Enrollment in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis - PR Newswire

pulisher
PR Newswire

DURECT Announces Peer-Reviewed Article Accepted for Publication with Additional Data from Previously Completed ... - Yahoo Finance

pulisher
Yahoo Finance

Acute Kidney Injury (AKI) Disease Treatment Market Report 2023: Featuring Exponential Biotherapies, AM-Pharma ... - Yahoo Finance UK

pulisher
Yahoo Finance UK

BUZZ-U.S. STOCKS ON THE MOVE-Fat Brands, Spotify, Uber Tech - Nasdaq

pulisher
Nasdaq

Microbial Products Market Size to Worth Around USD 302 Bn by 2030 - GlobeNewswire

pulisher
GlobeNewswire

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accep - Benzinga

pulisher
Benzinga
$65.00
price down icon 2.30%
$17.19
price up icon 1.24%
$55.37
price up icon 0.22%
drug_manufacturers_specialty_generic RDY
$68.26
price down icon 1.50%
$10.98
price down icon 0.36%
$142.29
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):